Penumbra Inc has a consensus price target of $283.33 based on the ratings of 16 analysts. The high is $376 issued by Deutsche Bank on June 26, 2023. The low is $210 issued by Morgan Stanley on July 15, 2024. The 3 most-recent analyst ratings were released by Truist Securities, Morgan Stanley, and BTIG on July 16, 2024, July 15, 2024, and July 15, 2024, respectively. With an average price target of $224 between Truist Securities, Morgan Stanley, and BTIG, there's an implied 17.98% upside for Penumbra Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2024 | Buy Now | 21.14% | Truist Securities | Richard Newitter | $280 → $230 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | 10.6% | Morgan Stanley | Kallum Titchmarsh | $235 → $210 | Maintains | Equal-Weight | Get Alert |
07/15/2024 | Buy Now | 22.19% | BTIG | Ryan Zimmerman | $265 → $232 | Maintains | Buy | Get Alert |
07/10/2024 | Buy Now | 39.57% | Citigroup | Joanne Wuensch | $300 → $265 | Maintains | Buy | Get Alert |
05/08/2024 | Buy Now | 43.26% | Canaccord Genuity | Jason Mills | $284 → $272 | Maintains | Buy | Get Alert |
05/08/2024 | Buy Now | 36.94% | Piper Sandler | Matt O'Brien | $290 → $260 | Maintains | Overweight | Get Alert |
05/08/2024 | Buy Now | — | Needham | Mike Matson | — | Reiterates | → Hold | Get Alert |
04/03/2024 | Buy Now | 52.74% | Piper Sandler | Matt O'Brien | $290 → $290 | Reiterates | Overweight → Overweight | Get Alert |
03/22/2024 | Buy Now | 47.47% | Truist Securities | Richard Newitter | $290 → $280 | Maintains | Buy | Get Alert |
02/23/2024 | Buy Now | 52.74% | Piper Sandler | Matt O'Brien | $310 → $290 | Reiterates | Overweight → Overweight | Get Alert |
02/23/2024 | Buy Now | 52.21% | RBC Capital | Shagun Singh | → $289 | Reiterates | Outperform → Outperform | Get Alert |
02/23/2024 | Buy Now | 49.58% | Canaccord Genuity | William Plovanic | → $284 | Reiterates | Buy → Buy | Get Alert |
02/23/2024 | Buy Now | 52.74% | Truist Securities | David Rescott | $300 → $290 | Maintains | Buy | Get Alert |
02/23/2024 | Buy Now | 31.67% | JP Morgan | Robbie Marcus | $284 → $250 | Downgrade | Overweight → Neutral | Get Alert |
01/12/2024 | Buy Now | 52.21% | RBC Capital | Shagun Singh | $280 → $289 | Maintains | Outperform | Get Alert |
01/11/2024 | Buy Now | 47.47% | RBC Capital | Shagun Singh | $248 → $280 | Maintains | Outperform | Get Alert |
12/22/2023 | Buy Now | 55.37% | Truist Securities | David Rescott | $265 → $295 | Maintains | Buy | Get Alert |
12/20/2023 | Buy Now | 49.58% | JP Morgan | Robbie Marcus | $240 → $284 | Maintains | Overweight | Get Alert |
12/12/2023 | Buy Now | 39.57% | Truist Securities | David Rescott | $240 → $265 | Maintains | Buy | Get Alert |
11/03/2023 | Buy Now | 31.67% | Piper Sandler | Matt O'Brien | $335 → $250 | Maintains | Overweight | Get Alert |
11/03/2023 | Buy Now | 26.4% | Morgan Stanley | Kallum Titchmarsh | $265 → $240 | Maintains | Equal-Weight | Get Alert |
10/02/2023 | Buy Now | 68.54% | Citigroup | Joanne Wuensch | $390 → $320 | Maintains | Buy | Get Alert |
09/19/2023 | Buy Now | 76.44% | Piper Sandler | Matt O'Brien | → $335 | Reiterates | Overweight → Overweight | Get Alert |
09/06/2023 | Buy Now | 39.57% | Morgan Stanley | Kallum Titchmarsh | → $265 | Initiates | → Equal-Weight | Get Alert |
08/17/2023 | Buy Now | 83.81% | RBC Capital | Shagun Singh | → $349 | Reiterates | Outperform → Outperform | Get Alert |
08/02/2023 | Buy Now | 69.59% | Canaccord Genuity | William Plovanic | $351 → $322 | Maintains | Buy | Get Alert |
08/02/2023 | Buy Now | 81.7% | Truist Securities | David Rescott | $370 → $345 | Maintains | Buy | Get Alert |
08/02/2023 | Buy Now | 77.49% | Wells Fargo | Larry Biegelsen | $320 → $337 | Maintains | Overweight | Get Alert |
07/19/2023 | Buy Now | 94.87% | Truist Securities | David Rescott | $350 → $370 | Maintains | Buy | Get Alert |
07/19/2023 | Buy Now | 97.5% | Baird | David Rescott | → $375 | Initiates | → Outperform | Get Alert |
07/12/2023 | Buy Now | 83.81% | RBC Capital | Shagun Singh | $303 → $349 | Maintains | Outperform | Get Alert |
07/11/2023 | Buy Now | 105.4% | Citigroup | Joanne Wuensch | $325 → $390 | Maintains | Buy | Get Alert |
06/26/2023 | Buy Now | 98.03% | Deutsche Bank | Pito Chickering | $325 → $376 | Maintains | Buy | Get Alert |
06/05/2023 | Buy Now | 72.75% | BTIG | Ryan Zimmerman | $312 → $328 | Maintains | Buy | Get Alert |
05/24/2023 | Buy Now | 76.44% | Piper Sandler | Matt O'Brien | $300 → $335 | Maintains | Overweight | Get Alert |
05/18/2023 | Buy Now | 84.34% | Truist Securities | David Rescott | $320 → $350 | Maintains | Buy | Get Alert |
05/03/2023 | Buy Now | 64.32% | BTIG | Ryan Zimmerman | $301 → $312 | Maintains | Buy | Get Alert |
05/03/2023 | Buy Now | 59.58% | RBC Capital | Shagun Singh | $289 → $303 | Maintains | Outperform | Get Alert |
05/03/2023 | Buy Now | 58% | Piper Sandler | Matt O'Brien | $285 → $300 | Maintains | Overweight | Get Alert |
05/03/2023 | Buy Now | 68.54% | Wells Fargo | Larry Biegelsen | $291 → $320 | Maintains | Overweight | Get Alert |
04/03/2023 | Buy Now | 71.17% | Citigroup | Joanne Wuensch | $303 → $325 | Maintains | Buy | Get Alert |
03/29/2023 | Buy Now | — | Needham | Mike Matson | — | Downgrade | Buy → Hold | Get Alert |
02/27/2023 | Buy Now | 59.58% | Citigroup | Joanne Wuensch | $270 → $303 | Maintains | Buy | Get Alert |
02/24/2023 | Buy Now | 50.63% | Canaccord Genuity | William Plovanic | $246 → $286 | Maintains | Buy | Get Alert |
02/24/2023 | Buy Now | 58% | Needham | Mike Matson | $235 → $300 | Maintains | Buy | Get Alert |
02/07/2023 | Buy Now | 56.42% | Deutsche Bank | Pito Chickering | $250 → $297 | Maintains | Buy | Get Alert |
02/01/2023 | Buy Now | 50.1% | JP Morgan | Robbie Marcus | $254 → $285 | Maintains | Overweight | Get Alert |
01/30/2023 | Buy Now | 49.58% | Truist Securities | David Rescott | $255 → $284 | Maintains | Buy | Get Alert |
01/30/2023 | Buy Now | 42.2% | BTIG | Ryan Zimmerman | $240 → $270 | Maintains | Buy | Get Alert |
01/30/2023 | Buy Now | 44.84% | Piper Sandler | Matt O'Brien | → $275 | Initiates | → Overweight | Get Alert |
12/20/2022 | Buy Now | 34.3% | Truist Securities | David Rescott | $228 → $255 | Maintains | Buy | Get Alert |
12/12/2022 | Buy Now | 34.3% | Wells Fargo | Larry Biegelsen | $225 → $255 | Maintains | Overweight | Get Alert |
12/12/2022 | Buy Now | 42.2% | Citigroup | Joanne Wuensch | $212 → $270 | Maintains | Buy | Get Alert |
12/05/2022 | Buy Now | 26.4% | BTIG | Ryan Zimmerman | $204 → $240 | Maintains | Buy | Get Alert |
11/04/2022 | Buy Now | 18.5% | Wells Fargo | Larry Biegelsen | $260 → $225 | Maintains | Overweight | Get Alert |
11/04/2022 | Buy Now | 23.77% | Needham | Mike Matson | $244 → $235 | Maintains | Buy | Get Alert |
11/04/2022 | Buy Now | 11.66% | Citigroup | Joanne Wuensch | $217 → $212 | Upgrade | Neutral → Buy | Get Alert |
10/12/2022 | Buy Now | 21.14% | Jefferies | Matthew Taylor | → $230 | Initiates | → Buy | Get Alert |
10/05/2022 | Buy Now | — | Citigroup | Joanne Wuensch | — | Downgrade | Buy → Neutral | Get Alert |
09/19/2022 | Buy Now | 25.88% | BTIG | Ryan Zimmerman | $213 → $239 | Maintains | Buy | Get Alert |
09/13/2022 | Buy Now | 21.14% | Truist Securities | David Rescott | $180 → $230 | Maintains | Buy | Get Alert |
09/09/2022 | Buy Now | 28.51% | Needham | Mike Matson | → $244 | Upgrade | Hold → Buy | Get Alert |
08/05/2022 | Buy Now | -0.46% | Canaccord Genuity | William Plovanic | $244 → $189 | Maintains | Buy | Get Alert |
07/21/2022 | Buy Now | -14.15% | Deutsche Bank | Pito Chickering | $250 → $163 | Maintains | Buy | Get Alert |
07/20/2022 | Buy Now | -5.2% | Truist Securities | David Rescott | $240 → $180 | Maintains | Buy | Get Alert |
07/18/2022 | Buy Now | 12.18% | BTIG | Ryan Zimmerman | $272 → $213 | Maintains | Buy | Get Alert |
07/18/2022 | Buy Now | 2.7% | RBC Capital | Shagun Singh | → $195 | Initiates | → Outperform | Get Alert |
05/17/2022 | Buy Now | 15.87% | Citigroup | Joanne Wuensch | $280 → $220 | Maintains | Buy | Get Alert |
05/04/2022 | Buy Now | 39.57% | Wells Fargo | Larry Biegelsen | $321 → $265 | Maintains | Overweight | Get Alert |
04/19/2022 | Buy Now | 31.67% | Deutsche Bank | Pito Chickering | → $250 | Initiates | → Buy | Get Alert |
03/08/2022 | Buy Now | — | Needham | Mike Matson | — | Initiates | → Hold | Get Alert |
02/23/2022 | Buy Now | 58% | Truist Securities | David Rescott | $350 → $300 | Maintains | Buy | Get Alert |
02/23/2022 | Buy Now | 47.47% | Citigroup | Joanne Wuensch | $300 → $280 | Maintains | Buy | Get Alert |
02/23/2022 | Buy Now | 58% | JP Morgan | Robbie Marcus | $325 → $300 | Maintains | Overweight | Get Alert |
09/22/2021 | Buy Now | 84.34% | Truist Securities | David Rescott | $350 → $350 | Maintains | Buy | Get Alert |
09/16/2021 | Buy Now | 84.34% | Truist Securities | — | — | Initiates | → Buy | Get Alert |
08/10/2021 | Buy Now | 62.22% | BTIG | Ryan Zimmerman | — | Maintains | Buy | Get Alert |
The latest price target for Penumbra (NYSE:PEN) was reported by Truist Securities on July 16, 2024. The analyst firm set a price target for $230.00 expecting PEN to rise to within 12 months (a possible 21.14% upside). 28 analyst firms have reported ratings in the last year.
The latest analyst rating for Penumbra (NYSE:PEN) was provided by Truist Securities, and Penumbra maintained their buy rating.
The last upgrade for Penumbra Inc happened on November 4, 2022 when Citigroup raised their price target to $212. Citigroup previously had a neutral for Penumbra Inc.
The last downgrade for Penumbra Inc happened on February 23, 2024 when JP Morgan changed their price target from $284 to $250 for Penumbra Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Penumbra, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Penumbra was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
While ratings are subjective and will change, the latest Penumbra (PEN) rating was a maintained with a price target of $280.00 to $230.00. The current price Penumbra (PEN) is trading at is $189.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.